Weiss Multi Strategy Advisers LLC Deciphera Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $82,490 - $397,773	-10,713 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $6,165 - $8,655	233 Added 2.22%	10,713 $364,000
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $12,241 - $17,933	374 Added 3.7%	10,480 $384,000
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $16,681 - $23,429	-413 Reduced 3.93%	10,106 $453,000
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $37,792 - $48,311	-730 Reduced 6.49%	10,519 $600,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $261,967 - $347,854	5,981 Added 113.53%	11,249 $577,000
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $42,311 - $74,264	-1,142 Reduced 17.82%	5,268 $315,000
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $215,568 - $444,854	6,410 New	6,410 $264,000
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $1.41 Million - $2.06 Million	-85,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $1.5 Million - $1.61 Million	85,000	85,000 $1.61 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.